Today, Allscripts (NASDAQ:MDRX), a global leader in health care information technology, announced a collaboration with Microsoft focused on implementing an innovative, integrated model for clinical research, aiming to enhance clinical research design, conduct studies more efficiently and improve the research provider and participant experience. 
Public sector cloud transformation specialists Shaping Cloud have chosen Highland Marketing as their marketing and PR partner to help them deliver their growth ambitions in the burgeoning health and care IT market and wider public sector. 
The surgical treatment of musculoskeletal conditions is at a high level thanks to continuous improvements in research and clinical care. The same applies to postoperative physiotherapy, which supports patients in their healing process. Most important for a comprehensive recovery however, are the patients themselves - through independent training outside the prescribed therapy sessions. 
EIT Health, a network of best-in-class innovators backed by the EU, has announced the second year of its innovation programme, Wild Card. The second year of high-risk innovation programme Wild Card kicks off this week, challenging talent to deliver real solutions to the healthcare market. 
Today, the U.S. Food and Drug Administration cleared a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with opioid use disorder (OUD). The reSET-O app is a prescription cognitive behavioral therapy intended to be used in addition to outpatient treatment under the care of a health care professional, 
German Accelerator Life Sciences Alumni company, SpinDiag, just announced the successful closing of 3 million Series A funding round. The Freiburg-based health tech startup addresses the challenge of patients introducing drug-resistant bacteria into hospitals. SpinDiag provides a rapid point-of-care screening system, SpinDiag one, to test high-risk patients for all relevant drug-resistances.